JnJ to buy rights to Numab Therapeutics Clinical-Stage Bispecific Antibody NM26 Ruchika Sharma29 May 2024 12:30 PM ISTNew Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement with Numab Therapeutics, a clinical-stage...
Johnson and Johnson Gets CDSCO Panel Nod For Additional Indication of Daratumumab to Treat Light chain AL amyloidosis Dr. Divya Colin25 May 2024 6:00 PM ISTNew Delhi: Granting local clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Johnson & Johnson to acquire Proteologix for USD 850 million in cash Ruchika Sharma20 May 2024 4:23 PM ISTNew Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement to acquire Proteologix, Inc., a privately-held...
JnJ submits regulatory applications to EMA for Tremfya for treatment of patients with ulcerative colitis, Crohn's disease Ruchika Sharma5 May 2024 1:30 PM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced it has submitted applications to the European Medicines...
Janssen to adopt Johnson & Johnson brand in UK Ruchika Sharma2 May 2024 12:51 PM ISTHigh Wycombe: Johnson & Johnson has announced it is updating its brand and uniting both its two business segments under the Johnson &...
JnJ gets positive CHMP opinion for Rybrevant, chemotherapy combo for first-line treatment of patients with advanced non-small cell lung cancer with activating EGFR exon 20 insertion mutations Ruchika Sharma28 April 2024 12:30 PM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...
Kenya drug regulator recalls a batch of JnJ children cough syrup Ruchika Sharma13 April 2024 4:15 PM ISTNairobi: Kenya's drug regulator said on thursday it is recalling a batch of Johnson & Johnson children's cough syrup, following...
USFDA approves Carvykti for patients with Relapsed or Refractory Multiple Myeloma who have received at least one prior line of therapy Ruchika Sharma7 April 2024 10:00 AM ISTHorsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved CARVYKTI (ciltacabtagene...
USFDA grants Fast Track designation to JnJ nipocalimab to reduce fetal neonatal alloimmune thrombocytopenia risk in alloimmunized pregnant adults Ruchika Sharma27 March 2024 12:30 PM ISTSpring House: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation (FTD) for...
JnJ gets USFDA nod for Opsynvi for chronic treatment of adults with pulmonary arterial hypertension Ruchika Sharma23 March 2024 12:23 PM ISTRaritan: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved OPSYNVI - a single-tablet combination...
USFDA nod to Johnson and Johnson EDURANT PED for certain pediatric patients living with HIV-1 Ruchika Sharma20 March 2024 12:30 PM ISTTitusville: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved EDURANT PED (rilpivirine) for the...
Need More Justification: CDSCO Panel rejects J&J protocol amendment proposal for Teclistamab study Dr. Divya Colin17 March 2024 5:45 PM ISTNew Delhi: Citing that more justification is required, the Subject Expert Committee SEC functional under the Central Drug Standard Control...
